-
Multiplexed ACE2 Libraries Reveal Variant-Specific SARS-CoV-
2026-06-03
This study introduces a barcoded, high-throughput infection assay to simultaneously assess how SARS-CoV-2 spike variants interact with a wide array of ACE2 receptor sequences. The findings illuminate variant-driven shifts in receptor usage, providing insight into mechanisms underpinning viral adaptation and potential cross-species transmission.
-
Neutrophil Traps Activate cGAS-STING in Surgical Brain Injur
2026-06-03
This study reveals that neutrophil extracellular traps (NETs) exacerbate surgical brain injury (SBI) by activating the cGAS-STING pathway, driving neuroinflammation and neuronal damage. The authors demonstrate that targeting NETs or the cGAS-STING axis can mitigate SBI outcomes, highlighting new therapeutic avenues for post-surgical neuroprotection.
-
Protoporphyrin IX: Photodynamic Compound for Advanced Assays
2026-06-02
Protoporphyrin IX is transforming cancer research and ferroptosis modeling with its unique photodynamic and iron-chelating properties. Discover how APExBIO’s high-purity compound enables robust, reproducible workflows and empowers translational breakthroughs in photodynamic cancer diagnosis and therapy.
-
TK1 in Uterine Corpus Endometrial Carcinoma: Expression, Pro
2026-06-02
This article critically reviews a comprehensive study analyzing thymidine kinase 1 (TK1) expression in uterine corpus endometrial carcinoma (UCEC), elucidating its prognostic relevance, regulatory mechanisms, and functional roles in tumor biology. Key findings reveal TK1 as a significant biomarker linked to poor clinical outcomes and as a regulator of cell proliferation and immune microenvironment in UCEC.
-
DAPT (GSI-IX): Optimizing Notch Pathway Inhibition Protocols
2026-06-01
DAPT (GSI-IX) empowers precision studies of Notch signaling and amyloid precursor protein processing across neurodegenerative and cancer research. This guide details advanced workflows, critical protocol parameters, and troubleshooting insights to maximize reproducibility and interpretive depth when leveraging APExBIO’s selective γ-secretase inhibitor.
-
CB-5083 in Oncology: Disrupting Protein and Lipid Homeostasi
2026-06-01
Discover how CB-5083, a potent p97 inhibitor, uniquely targets both protein and lipid homeostasis in cancer cells. This article explores advanced assay strategies and mechanistic insights, offering a fresh perspective on CB-5083’s applications beyond current literature.
-
HOBt (1-Hydroxybenzotriazole): Precision in Peptide Synthesi
2026-05-31
HOBt (1-Hydroxybenzotriazole) streamlines amide bond formation and minimizes epimerization in peptide synthesis, making it indispensable for both routine and advanced workflows. Explore stepwise protocols, troubleshooting strategies, and insights from recent glucagon receptor antagonist synthesis to unlock the full potential of this APExBIO reagent.
-
Practical Guide: EdU Imaging Kits (HF594) for DNA Synthesis
2026-05-30
EdU Imaging Kits (HF594) offer a sensitive, antibody-free approach for measuring DNA synthesis and cell proliferation using 5-ethynyl-2’-deoxyuridine (EdU) incorporation. These kits are recommended where precise S-phase detection and compatibility with fluorescence microscopy or flow cytometry are required. They are not advised in workflows incompatible with copper-catalyzed click chemistry or for live-cell, real-time tracking.
-
Valemetostat (BA4816): Reliable EZH2 Inhibition for Lymphoma
2026-05-29
This article provides practical, scenario-driven guidance for integrating Valemetostat (SKU BA4816) into epigenetic cancer therapy workflows. Drawing on quantitative evidence and real-world challenges, it shows how Valemetostat delivers reproducible, mutation-spanning EZH2 inhibition for lymphoma research, with a focus on reliability and compatibility in cell-based assays.
-
KU-55933 (ATM Kinase Inhibitor): Reliable Solutions for DNA
2026-05-29
This article provides scenario-driven, evidence-based guidance for maximizing reproducibility and scientific insight using KU-55933 (ATM Kinase Inhibitor, SKU A4605) in cell viability, proliferation, and DNA damage response research. Drawing on real laboratory challenges, validated protocol parameters, and cited literature, it demonstrates how SKU A4605 offers bench-proven performance for advanced biomedical applications.
-
ICG–MXene/Bletilla Hydrogel: Synergistic Antibacterial and W
2026-05-28
This study introduces a nanocomposite hydrogel integrating indocyanine green-loaded MXene nanosheets and Bletilla striata polysaccharide for combined photothermal-photodynamic antibacterial therapy and wound repair. The material demonstrates high adhesiveness, biocompatibility, and potent antibacterial activity, offering a promising alternative to traditional wound dressings, especially against resistant Staphylococcus aureus infections.
-
Optimizing Protein Extraction with Protease Inhibitor Cockta
2026-05-28
This article provides a scenario-driven, evidence-based exploration of laboratory challenges in protein extraction and assay workflows, focusing on how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO, SKU K1007) addresses core pain points. Practical Q&A blocks guide researchers to improve reproducibility, compatibility, and data integrity using this APExBIO formulation.
-
In Vivo CRISPR Screens Reveal GRA12 as a Broad Toxoplasma Vi
2026-05-27
This study employs systematic in vivo CRISPR-Cas9 screening to identify GRA12 as a conserved and essential secreted virulence factor in Toxoplasma gondii across multiple parasite strains and mouse subspecies. The findings clarify how GRA12 protects the parasite from immune clearance, providing new insights into host-pathogen interactions and highlighting potential translational opportunities for targeting conserved effectors.
-
CFDA SE Cell Tracer Kit: Technical Guide for Cell Tracing Wo
2026-05-27
The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides a robust, covalent fluorescent labeling solution for researchers conducting long-term cell lineage tracing or cell proliferation studies. It is most suitable for applications requiring durable, persistent labeling of cell populations, but is not recommended for workflows needing reversible, short-term, or real-time physiological cell tracking.
-
Kinome Inhibitor Screening Reveals Mechanisms of Post-Caspas
2026-05-26
This study pioneers a quantitative kinome inhibitor screen to systematically identify signaling pathways that enable cell survival after executioner caspase activation—a phenomenon called anastasis. By distinguishing survival-specific pathways from general toxicity, the research pinpoints adhesion and growth factor signaling as critical modulators, with implications for both cancer therapy and regenerative biology.